Gray HJ - Search Results

1

A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

Bender D, Sill MW, Lankes HA, Reyes HD, Darus CJ, Delmore JE, Rotmensch J, Gray HJ, Mannel RS, Schilder JM, Hunter MI, McCourt CK, Samuelson MI, Leslie KK. Bender D, et al. Among authors: gray hj. Gynecol Oncol. 2015 Sep;138(3):507-12. doi: 10.1016/j.ygyno.2015.07.018. Epub 2015 Jul 15. Gynecol Oncol. 2015. PMID: 26186911 Free PMC article. Clinical Trial.

2

Glassy cell carcinoma of the cervix revisited.

Gray HJ, Garcia R, Tamimi HK, Koh WJ, Goff BA, Greer BE, Paley PJ. Gray HJ, et al. Gynecol Oncol. 2002 May;85(2):274-7. doi: 10.1006/gyno.2001.6523. Gynecol Oncol. 2002. PMID: 11972387

3

Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma.

Garg R, Wollan M, Galic V, Garcia R, Goff BA, Gray HJ, Swisher E. Garg R, et al. Among authors: gray hj. Gynecol Oncol. 2006 Dec;103(3):793-6. doi: 10.1016/j.ygyno.2006.08.043. Epub 2006 Oct 4. Gynecol Oncol. 2006. PMID: 17023036 Free PMC article.

4

An evaluation of cervical cancer in women age sixty and over.

Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Gray HJ, Swensen RE, Goff BA. Fox KV, et al. Among authors: gray hj. Gynecol Oncol. 2008 Apr;109(1):53-8. doi: 10.1016/j.ygyno.2007.12.028. Epub 2008 Feb 5. Gynecol Oncol. 2008. PMID: 18255127

5

Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman LD. Monk BJ, et al. Among authors: gray hj. J Clin Oncol. 2009 Mar 1;27(7):1069-74. doi: 10.1200/JCO.2008.18.9043. Epub 2009 Jan 12. J Clin Oncol. 2009. PMID: 19139430 Free PMC article. Clinical Trial.

6

Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.

Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA. Gray HJ, et al. Gynecol Oncol. 2010 Mar;116(3):340-4. doi: 10.1016/j.ygyno.2009.10.054. Epub 2009 Nov 17. Gynecol Oncol. 2010. PMID: 19922987

7

Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction.

McLean KA, Shah CA, Thompson SA, Gray HJ, Swensen RE, Goff BA. McLean KA, et al. Among authors: gray hj. Gynecol Oncol. 2010 Jul;118(1):43-6. doi: 10.1016/j.ygyno.2010.03.002. Epub 2010 Apr 27. Gynecol Oncol. 2010. PMID: 20398918

8

FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.

Press JZ, Allison KH, Garcia R, Everett EN, Pizer E, Swensen RE, Tamimi HK, Gray HJ, Peters WA 3rd, Goff BA. Press JZ, et al. Among authors: gray hj. Gynecol Oncol. 2011 Feb;120(2):296-9. doi: 10.1016/j.ygyno.2010.10.019. Gynecol Oncol. 2011. PMID: 21075432

9

Pelvic exenteration in the age of modern chemoradiation.

McLean KA, Zhang W, Dunsmoor-Su RF, Shah CA, Gray HJ, Swensen RE, Goff BA. McLean KA, et al. Among authors: gray hj. Gynecol Oncol. 2011 Apr;121(1):131-4. doi: 10.1016/j.ygyno.2010.11.044. Epub 2011 Jan 21. Gynecol Oncol. 2011. PMID: 21256580

10

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.

Thrall MM, Gray HJ, Symons RG, Weiss NS, Flum DR, Goff BA. Thrall MM, et al. Among authors: gray hj. Gynecol Oncol. 2011 Jul;122(1):100-6. doi: 10.1016/j.ygyno.2011.03.022. Epub 2011 Apr 15. Gynecol Oncol. 2011. PMID: 21496889 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page